API reference
Norgestimate
- CAS number
- 35189-28-7
- Molecular formula
- C23H31NO3
- Molecular weight
- 369.5 g/mol
About this molecule
Norgestimate was first described in the literature in 1977. It was developed by Ortho Pharmaceutical Corporation as part of an effort to develop new hormonal contraceptives with reduced adverse effects. It is commonly formulated with [ethinylestradiol] as a combined oral contraceptive that can also be used to treat moderate acne vulgaris. Norgestimate was granted FDA approval on 29 December 1989.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
- InChIKey
- KIQQMECNKUGGKA-NMYWJIRASA-N
- SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=C/C(=N/O)/CC[C@H]34
- Other CAS numbers recorded
- 107382-52-5
- PubChem CID
- 6540478
Also known as
Dexnorgestrel acetime · Norgestimato · Norgestimatum · D-138 · anti-Norgestimate · Norgestimate, E- · Norgestimate (USP/INN) · dexnorgestrel
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.